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Plants have been used over centuries in traditional medicine for the treatment of human diseases. In 
the last decades the interest in medicinal plants has increased significantly owing to the antioxidant 
effect found in their natural extracts which is responsible for many therapeutic effects. The Ginkgo biloba 
leaf extract (GBE), widely used in traditional Chinese medicine, is nowadays intensively studied and 
sold all over the world due to its many health benefits, being used for the treatment of human pathologies 
such as neurodegenerative and cardiovascular diseases, and also to delay the ageing process. 
Although the antioxidant properties of GBE are well documented 1-3, studies on the antigenotoxic 
activity of GBE are still scarce. 
 
The colonic environment is continuously exposed to a large diversity of dietary compounds, some of 
them potentially carcinogenic, that may affect DNA integrity (e.g.: DNA oxidation and strand breaks) and 
alter cell genetic information, contributing to the development of colorectal cancer (CRC). Diets that are 
mainly composed of fruits and vegetables are rich in polyphenols and have been associated with CRC 
prevention 4. Medicinal plant extracts may also be rich in polyphenols and can be used to prevent or 
reduce DNA damage. 
 
The chemical analysis of the ethanolic GBE allowed the identification of some G. biloba characteristic 
compounds, being mainly composed of one type of polyphenols designed as flavonoids, which are 
known for having strong antioxidant activity. Owing to this property, GBE could be a potential 
chemopreventive agent against CRC. Thus, GBE was subjected to simulated in vitro human digestion 
of the upper tract, originating a product (DGBE) that represents the extract when it reaches the colon 
during human digestion. GBE and DGBE demonstrated in vitro antioxidant activity and were tested in 
human colorectal adenocarcinoma cell line for their cytotoxicity (MTT assay) and antigenotoxicity (comet 
assay), where cells were pre-treated with each extract and subsequently challenged with H2O2. Both 
forms of the extract did not affect cell viability and decreased the level of DNA damage induced by 
oxidative stress. GBE and DGBE seem to be protecting DNA from damage, which could be the result 
of the stimulation of antioxidant defence mechanisms (such as the induction of antioxidant enzymatic 
activity or non-enzymatic defences) and DNA repair, or the extracts might be inducing moderate stress 
in cells, causing cell adaption when exposed to H2O2. Therefore, GBE shows a potential antigenotoxic 
effect, that seems to be retained after the digestive process, and might be the result of the antioxidant 
properties provided by the flavonoid fraction of the extract.  
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